135 related articles for article (PubMed ID: 6466536)
41. Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases.
Luesley DM; Chan KK; Fielding JW; Hurlow R; Blackledge GR; Jordon JA
Obstet Gynecol; 1984 Sep; 64(3):421-6. PubMed ID: 6462573
[TBL] [Abstract][Full Text] [Related]
42. The role of second-look laparotomy in the management of patients with ovarian carcinoma.
Rome RM; Fortune DW
Aust N Z J Obstet Gynaecol; 1988 Nov; 28(4):318-23. PubMed ID: 3250451
[TBL] [Abstract][Full Text] [Related]
43. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
44. A comparison of low- and high-dose cisplatin-based combination chemotherapy as initial postoperative treatment in advanced ovarian adenocarcinoma.
Menczer J; Brenner J; Modan M; Ben-Baruch G; Brenner H
Am J Obstet Gynecol; 1986 Nov; 155(5):974-9. PubMed ID: 3777073
[TBL] [Abstract][Full Text] [Related]
45. [Significance of second look surgery in the therapy of ovarian cancer].
Sasaki H; Ochiai K; Terashima Y
Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
[TBL] [Abstract][Full Text] [Related]
46. Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.
Williams CJ; Mead GM; Macbeth FR; Thompson J; Whitehouse JM; MacDonald H; Harvey VJ; Slevin ML; Lister TA; Shepherd JH
J Clin Oncol; 1985 Nov; 3(11):1455-62. PubMed ID: 3903062
[TBL] [Abstract][Full Text] [Related]
47. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.
J Clin Oncol; 1991 Sep; 9(9):1668-74. PubMed ID: 1831495
[TBL] [Abstract][Full Text] [Related]
48. [Reassessment of second-look operations (SLO) in the treatment of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1303-9. PubMed ID: 2730043
[TBL] [Abstract][Full Text] [Related]
49. A second thought on second look laparotomy.
Bar-Am A; Kovner F; Lessing JB; Inbar M; Chaitchik S; Azem F; Brenner SH; Peyser MR
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):386-90. PubMed ID: 8392272
[TBL] [Abstract][Full Text] [Related]
50. [Studies of second-look operations (SLO) in ovarian cancer].
Yuzawa H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
[TBL] [Abstract][Full Text] [Related]
51. The influence of initial residual disease on the outcome of second-look laparotomy in patients with carcinoma of the ovary.
Soeters RP; Bloch B; Dehaeck K; Levin W
Eur J Gynaecol Oncol; 1992; 13(3):223-7. PubMed ID: 1618220
[TBL] [Abstract][Full Text] [Related]
52. Second-look laparotomy in carcinoma of the fallopian tube.
Barakat RR; Rubin SC; Saigo PE; Lewis JL; Jones WB; Curtin JP
Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320
[TBL] [Abstract][Full Text] [Related]
53. The role of second-look laparotomy in the long-term survival in ovarian cancer.
Tuxen MK; Strauss G; Lund B; Hansen M
Ann Oncol; 1997 Jul; 8(7):643-8. PubMed ID: 9296216
[TBL] [Abstract][Full Text] [Related]
54. Second-look laparotomy and salvage therapy: a research modality only?
Potter ME; Hatch KD; Soong SJ; Partridge EE; Austin JM; Shingleton HM
Gynecol Oncol; 1992 Jan; 44(1):3-9. PubMed ID: 1303613
[TBL] [Abstract][Full Text] [Related]
55. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.
Omura GA; Bundy BN; Berek JS; Curry S; Delgado G; Mortel R
J Clin Oncol; 1989 Apr; 7(4):457-65. PubMed ID: 2926470
[TBL] [Abstract][Full Text] [Related]
56. [Adjuvant chemotherapy of cancer of the ovary].
Cappelaere P; Horner-Vallet D; Demaille A
Bull Cancer; 1984; 71(4):363-9. PubMed ID: 6498348
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the second-look laparotomy in the management of carcinoma of the ovary.
Yakushiji M; Kato T
Semin Surg Oncol; 1986; 2(2):72-5. PubMed ID: 3454039
[TBL] [Abstract][Full Text] [Related]
58. A formula for predicting the risk of a positive second-look laparotomy in epithelial ovarian cancer: implications for a randomized trial.
Morgan MA; Noumoff JS; King S; Mikuta JJ
Obstet Gynecol; 1992 Dec; 80(6):944-8. PubMed ID: 1333064
[TBL] [Abstract][Full Text] [Related]
59. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
[TBL] [Abstract][Full Text] [Related]
60. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
